IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v430y2004i7001d10.1038_nature02764.html
   My bibliography  Save this article

Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5

Author

Listed:
  • Yongliang Zhang

    (University of Washington
    University of Texas, MD Anderson Cancer Center)

  • Joseph N. Blattman

    (University of Washington)

  • Norman J. Kennedy

    (University of Massachusetts)

  • Julie Duong

    (University of Washington)

  • Thang Nguyen

    (University of Washington)

  • Ying Wang

    (University of Washington)

  • Roger J. Davis

    (University of Massachusetts)

  • Philip D. Greenberg

    (University of Washington)

  • Richard A. Flavell

    (Yale University)

  • Chen Dong

    (University of Washington
    University of Texas, MD Anderson Cancer Center)

Abstract

Mitogen-activated protein (MAP) kinases are essential regulators in immune responses1, and their activities are modulated by kinases and phosphatases. MAP kinase phosphatase (MKP) is a family of dual-specificity phosphatases whose function is evolutionarily conserved2,3. A number of mammalian MKPs have been identified so far2,3, but their specific physiological functions in negative regulation of MAP kinases have not been genetically defined. Here we examine innate and adaptive immune responses in the absence of MKP5. JNK activity was selectively increased in Mkp5 (also known as Dusp10)-deficient mouse cells. Mkp5-deficient cells produced greatly enhanced levels of pro-inflammatory cytokines during innate immune responses and exhibited greater T-cell activation than their wild-type counterparts. However, Mkp5-deficient T cells proliferated poorly upon activation, which resulted in increased resistance to experimental autoimmune encephalomyelitis. By contrast, Mkp5-deficient CD4+ and CD8+ effector T cells produced significantly increased levels of cytokines compared with wild-type cells, which led to much more robust and rapidly fatal immune responses to secondary infection with lymphocytic choriomeningitis virus. Therefore, MKP5 has a principal function in both innate and adaptive immune responses, and represents a novel target for therapeutic intervention of immune diseases.

Suggested Citation

  • Yongliang Zhang & Joseph N. Blattman & Norman J. Kennedy & Julie Duong & Thang Nguyen & Ying Wang & Roger J. Davis & Philip D. Greenberg & Richard A. Flavell & Chen Dong, 2004. "Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5," Nature, Nature, vol. 430(7001), pages 793-797, August.
  • Handle: RePEc:nat:nature:v:430:y:2004:i:7001:d:10.1038_nature02764
    DOI: 10.1038/nature02764
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature02764
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature02764?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Nils-Petter Rudqvist & Maud Charpentier & Claire Lhuillier & Erik Wennerberg & Sheila Spada & Caroline Sheridan & Xi Kathy Zhou & Tuo Zhang & Silvia C. Formenti & Jennifer S. Sims & Alicia Alonso & Sa, 2023. "Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors," Nature Communications, Nature, vol. 14(1), pages 1-23, December.
    2. Bei Li & Guohao Wang & Kai Miao & Aiping Zhang & Liangyu Sun & Xinwang Yu & Josh Haipeng Lei & Lisi Xie & Jie Yan & Wenxi Li & Chu-Xia Deng & Yunlu Dai, 2023. "Fueling sentinel node via reshaping cytotoxic T lymphocytes with a flex-patch for post-operative immuno-adjuvant therapy," Nature Communications, Nature, vol. 14(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:430:y:2004:i:7001:d:10.1038_nature02764. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.